Pleiotropic Effects of Platelet P2Y<sub>12</sub> Receptor Inhibitors: Fact or Fiction?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|28|4597-4604

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.28, 2014-08, pp. : 4597-4604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects Of A Selective Histamine H<sub>4</sub>R Antagonist On Inflammation In A Model Of Carrageenan-Induced Pleurisy In The Rat

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1338-1344

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and AntitumorActivities of Bis-arylureas and Bisarylamides Based on 1H-benzo[d]imidazole Moiety as Novel BRaf <sup>V600E</sub>/VEGFR2 Dual Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 9, 2014-11 ,pp. : 1079-1089

Bentham Science Publishers

Access to resources Recommend Favorite

A New Battlefield Towards Global Health in 21<sup>st</sup> Century: Clinical Research Networks

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 2, 2014-08 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite

Biology and Pharmacology of the Platelet P2Y12 Receptor

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1255-1259

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet P2Y12 receptor inhibition by thienopyridines: status and future

By Porto Italo   Giubilato Simona   De Maria Giovanni Luigi   Biasucci Luigi Marzio   Crea Filippo  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 9, 2009-09 ,pp. : 1317-1332

Informa Healthcare

Access to resources Recommend Favorite